Intercure Financials - Benzinga

Intercure Ltd

INCRNASDAQ

Trade with Public

Trade with Public

$5.42

0.163.04%

At close: Sep 4, 5:00 PM EST

$5.37

-0.05-0.92%

After Hours: Sep 4, 4:48 AM EST

Overview News Earnings ForecastFinancialsSentiment Ownership Compare Options Stock Report

Intercure Financials

Intercure (INCR) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Intercure H1 EPS $0.01 Up From $0.00 YoY, Sales $36.292M Miss $66.530M Estimate

Intercure (NASDAQ:INCR) reported quarterly earnings of $0.01 per share. This is a 700 percent increase over earnings of $0.00 per share from the same period last year. The company reported quarterly sales of $36.292

Benzinga Newsdesk

PRO
InterCure Annual Revenue For The Year Ended December 31, 2024 Was NIS239 Million

Benzinga Newsdesk

Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany

Nina Zdinjak

PRO
InterCure H1 Revenue NIS125.733M Down From NIS208.614M YoY, Adjusted EBITDA NIS20.829M Down From NIS29.669M YoY

Revenues for the first half of 2024 were affected by damages caused by the terrorist attack on October 7, 2023, and the war in Gaza. InterCure is entitled to full compensation from the Israeli authorities for all

Benzinga Newsdesk

InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion

"Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges.

Rolando García

PRO
InterCure FY23 Revenue NIS356M

Benzinga Newsdesk